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Abstract 
The enantioselective synthesis of the C3–C15 bis-oxane segment of the phorboxazoles has been accomplished 
from 3-t-butyldiphenylsilyloxypropanal in 9 steps (>90% ee). 
 
The phorboxazoles A and B (1a and b) are isomeric macrolides isolated from the marine sponge Phorbas sp.1a In 
addition to exhibiting antifungal activity against Candida albicans, both phorboxazoles gave mean 
GI50s<8×10−10 M against most of the 60 tumor cell lines in the NCI panel. The complex structure of 1 consists of 
four oxane rings, two oxazole rings, 15 asymmetric centers, and a conjugated diene segment. The complete 
structure was assigned on the basis of NMR spectral studies, Mosher ester data, degradation, and model 
synthesis.1 The outstanding biological activity of 1, combined with its complex structural architecture, has led to 
significant activity by a number of research groups,2 and a total synthesis by Forsyth’s group.3 Recent reports by 
Hoffmann,2c Smith2d and Pattenden2e have prompted us to report our own efforts on the synthesis of the C3–
C15 bis-oxane segment 2. 
 
Lewis acid catalysed diene-aldehyde cyclocondensation4 of 3 with 4 in the presence of BF3·Et2O, followed by 
brief treatment with CF3CO2H gave dihydropyrone rac-5 (Scheme 1). In our hands attempted asymmetric 
cyclocondensation by a number of literature procedures proved capricious.5 For this reason, establishment of 
optical activity was deferred to a later stage. Oxymercuration/reduction of 5 followed by reduction 
[LiAlH(OtBu)3] and acylation gave 6. Reaction of 6 with allyl trimethylsilane/TMSOTf/CH3CN6 gave the α-C-
glucoside 7, which upon ozonolysis gave the aldehyde rac-8. The synthesis of a similar aldehyde was reported by 
Hoffmann’s group2c beginning from 8-oxabicyclo[3.2.1]octan-3-one (11 steps), and by Smith’s group2d beginning 
from 2,4-pentandione (12 steps); our route to 8 is significantly shorter (six steps). 
 
Scheme 1. (P=TBDPS) 
Chiral allylation of rac-8 with B-allyldiisopinocampheylborane (prepared from (−)-(IPC)2BOMe),7 followed by 
oxidative work up with NaBO3, gave a separable mixture of the diastereomers (+)-9 and (−)-10 (41 and 42%, 
respectively). The absolute stereochemistry of each alcohol at C11 was assigned as (S) on the basis of the 
relative chemical shifts of their (R)- and (S)-Mosher’s esters (>90% de each). 
Ring closing metathesis8 has recently found utility in the preparation of unsaturated δ-lactones.9 To this end, 
esterification of (−)-10 with acryloyl chloride gave (−)-11, which upon treatment with with Grubbs’ catalyst (0.3 
equivalents) gave the unsaturated pyrone (−)-2.10 
In summary, the C3–C15 bis-oxane segment of the phorboxazoles has been prepared in nine steps. Studies 
directed toward the preparation of other portions of the phorboxazoles continues in our laboratory. 
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